Systemic and mucosal immune responses after intranasal administration of recombinant Mycobacterium bovis bacillus Calmette-Guerin expressing glutathione S-transferase from Schistosoma haematobium

Infection and Immunity

Volumn 66, Issue 12, 1998, Pages 5669-5676

  Kremer, Laurent ^a,b   Dupré, Loïc ^a   Riveau, Gilles ^a   Capron, André ^a   Locht, Camille ^a  

^a INSTITUT PASTEUR DE LILLE   (France)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; GLUTATHIONE TRANSFERASE; IMMUNOGLOBULIN A; RECOMBINANT BCG VACCINE; RECOMBINANT VACCINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ARTICLE; ENZYME ACTIVITY; ENZYME ASSAY; FEMALE; GENETIC ENGINEERING; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOASSAY; IMMUNOGENICITY; INTRANASAL DRUG ADMINISTRATION; INTRAPERITONEAL DRUG ADMINISTRATION; LUNG LAVAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SCHISTOSOMA HEMATOBIUM; SCHISTOSOMIASIS;

MYCOBACTERIUM BOVIS; SCHISTOSOMA HAEMATOBIUM;

EID: 0031772432     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.66.12.5669-5676.1998     Document Type: Article

References (32)

1. Barclay W. R., W. M. Busey, D. W. Dalgard, R. C. Good, B. W. Janicki, J. E. Kasik, E. Ribi, C. E. Ulrich, and E. Wolinsky. 1973. Protection of monkeys against airborne tuberculosis by aerosol vaccination with Bacillus Calmette-Guérin. Am. Rev. Respir. Dis. 107:351-358.
2. Baulard, A., V. Escuyer, N. Haddad, L. Kremer, C. Locht, and P. Berche. 1994. Mercury resistance as a selective marker for recombinant mycobacteria. Microbiology 141:1045-1050.
3. Baulard, A., C. Jourdan, A. Mercenier, and C. Locht. 1992. Rapid mycobacterial plasmid analysis by electroduction between Mycobacterium spp. and Escherichia coli. Nucleic Acids Res. 20:4105.
4. Baulard, A., L. Kremer, P. Supply, D. Vidaud, J. M. Bidart, D. Bellet, and C. Locht. 1996. A new series of mycobacterial expression vectors for the development of live recombinant vaccines. Gene 176:149-154.
5. Colditz G. A., T. F. Brewer, C. S. Berkey, M. E. Wilson, E. Burdick, H. V. Fineberg, and F. Mosteller. 1994. Efficacy of BCG vaccine in the prevention of tuberculosis: meta-analysis of the published literature. JAMA 271:698-702.
6. de Aizpurua, H. J., and G. J. Russell-Jones. 1988. Oral vaccination: identification of classes of proteins that provoke an immune response upon oral feeding. J. Exp. Med. 167:440-451.
7. Gaudier, B., and C. Gernez-Rieux. 1962. Etude expérimentale de la vitalité du BCG au cours de la traversée gastro-intestinale chez des enfants non allergiques vaccinés par voie digestive. Ann. Inst. Pasteur (Lille) 13:77-87.
8. Grzych J. M., D. Grezel, C. B. Xu, J. L. Neyrinck, M. Capron, J. H. Ouma, A. E. Butterworth, and A. Capron. 1993. IgA antibodies to a protective antigen in human Schistosomiasis mansoni. J. Immunol. 150:527-535.
9. Heurtier, Y., F. Lamothe, M. Develoux, J. Docquier, F. Mouchet, E. Sellin, and B. Sellin. 1986. Urinary tract lesions due to Schistosoma haematobium infection assessed by ultrasonography in a community based study in Niger. Am. J. Trop. Med. Hyg. 35:1163-1172.
10. Hirabayashi, Y., H. Kurata, H. Funato, T. Nagamine, C. Aizawa, S. Tamura, K. Shimada, and T. Kurata. 1990. Comparison of intranasal inoculation of influenza HA vaccine combined with cholera toxin B subunit with oral or parenteral vaccination. Vaccine 8:243-248.
11. Hormaeche, C. E., and C. M. A. Khan. 1996. Recombinant bacteria as vaccine carriers of heterologous antigens, p. 327-359. In S. H. E. Kaufmann (ed.), Concepts in vaccine development. Walter de Gruyter, Berlin, Germany.
12. Jacobs, W. R., Jr., S. B. Snapper, L. Lugosi, and B. R. Bloom. 1990. Development of BCG as recombinant vaccine delivery vehicle. Curr. Top. Microbiol. Immunol. 155:153-160.
13. Kremer, L., A. Baulard, J. Estaquier, J. Content, A. Capron, and C. Locht. 1995. Analysis of the Mycobacterium tuberculosis 85A antigen promoter region J. Bacteriol. 177:642-653.
14. Kremer, L., A. Baulard, J. Estaquier, O. Poulain-Godefroy, and C. Locht. 1995. Green fluorescent protein as a new expression marker in mycobacteria. Mol. Microbiol. 17:913-922.
15. Kremer, L., G. Riveau, A. Baulard, A. Capron, and C. Locht. 1996. Neutralizing antibody responses elicited in mice immunized with recombinant Bacillus Calmette-Guérin producing the Schistosoma mansoni glutathione S-transferase. J. Immunol. 156:4309-4317.
16. Labidi, A., H. L. David, and D. Roulland-Dussoix. 1985. Restriction endo-nuclease mapping and cloning of Mycobacterium fortuitum var. fortuitum plasmid pAL5000. Ann. Inst. Pasteur Microbiol. 136:209-215.
17. Laemmli, U. K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685.
18. Lagranderie, M., A. M. Balazuc, B. Gicquel, and M. Gheorghiu. 1997. Oral immunization with recombinant Mycobacterium bovis BCG simian immunodeficiency virus nef induces local and systemic cytotoxic T-lymphocyte responses in mice. J. Virol. 71:2303-2309.
19. Langermann, S., S. R. Palaszynski, J. E. Burlein, S. Koenig, M. S. Hanson, D. E. Briles, and C. K. Stover. 1994. Protective humoral response against pneumococcal infection in mice elicited by recombinant Bacille Calmette-Guérin vaccines expressing pneumococcal surface protein A. J. Exp. Med. 180:2277-2286.
20. Langermann, S., S. Palaszynski, A. Sadziene, C. K. Stover, and S. Koenig. 1994. Systemic and mucosal immunity induced by BCG vector expressing outer-surface protein A of Borrelia burgdorferi. Nature 372:552-555.
21. Mielcarek, N., J. Cornette, A.-M. Schacht, R. J. Pierce, C. Locht, A. Capron, and G. Riveau. 1997. lntranasal priming with recombinant Dordetella pertussis for the induction of a systemic immune response against a heterologous antigen. Infect. Immun. 65:544-550.
22. Ndhlovu, P., H. Cadman, B. J. Vennervald, N. O. Christensen, M. Chidimu, and S. K. Chandiwana. 1996. Age-related antibody profiles in Schistosoma haematobium infections in a rural community in Zimbabwe. Parasite Immunol. 18:181-191.
23. Riveau G. J., and A. Capron. 1996. Vaccination against schistosomiasis: ' concepts and strategies, p. 509-532. In S. H. E. Kaufmann (ed.), Concepts in vaccine development. Walter de Gruyter, Berlin, Germany.
24. Rosenthal, S. R., J. T. McEnery, and N. Raisys. 1968. Aerogenic BCG vaccination against tuberculosis in animal and human subjects. J. Asthma Res. 5:309-323.
25. Sambrook, J., F. E. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
26. Sauton, B. 1912. Sur la nutrition minérale du bacille tuberculeux. C. R. Acad. Sci. 155:860-861.
27. Stover, C. K., V. F. de la Cruz, T. R. Fuerst, J. E. Burlein, L. A. Benson, G. P. Bansal, J. F. Young, M. H. Lee, G. F. Hatfull, S. B. Snapper, R. G. Barletta, W. R. Jacobs, and B. R. Bloom. 1991. New use of BCG for recombinant vaccines. Nature 351:456-460.
28. Trottein F., C. Godin, R. J. Pierce, B. Sellin, M. G. Taylor, I. Gorillot, S. M. Sampaio, J. P. Lecocq, and A. Capron. 1992. Interspecies variation of schistosome 28 kDa glutathione S-transferase. Mol. Biochem. Parasitol. 54:63-72.
29. Wolowczuk, I., C. Auriault, M. Bossus, D. Boulanger, H. Gras-Masse, C. Mazingue, R. J. Pierce, D. Grezel, G. D. Reid, A. Tartar, and A. Capron. 1991. Antigenicity and immunogenicity of a multiple peptidic construction of the Schistosoma mansoni Sm28GST antigen in rat, mouse and monkey. Partial protection of Fischer rat after active immunization. J. Immunol. 146:1987-1995.
30. Wolowczuk, I., C. Auriault, H. Gras-Masse, C. Mazingue, C. Vendeville, A. Tartar and A. Capron. 1990. T-cell responsiveness towards various synthetic peptides of the P28 antigen in rat and mouse models during Schistosoma mansoni infection. Int. Arch. Allergy Appl. Immunol. 93:350-358.
31. Xu, C. B., C. Verwaerde, J. M. Grzych, J. Fontaine, and A. Capron. 1991. A monoclonal antibody blocking the Schistosoma mansoni 28-kDa glutathione S-transferase activity reduces female worm fecundity and egg viability. Eur. J. Immunol. 21:1801-1807.
32. Yasutomi, Y., S. Koenig, S. S. Haun, C. K. Stover, R. K. Jackson, P. Conrad, A. J. Conley, E. A. Emini, T. R. Fuerst, and N. L. Letvin. 1993. Immunization with recombinant BCG-SIV elicits SIV-specific cytotoxic T lymphocytes in rhesus monkeys. J. Immunol. 150:3101-3107.